Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism.

Watts, Nelson B; Bilezikian, John P; Bone, Henry G; Clarke, Bart L; Denham, Douglas; Levine, Michael A; Mannstadt, Michael; Peacock, Munro; Rothman, Jeffrey G; Vokes, Tamara J; Warren, Mark L; Yin, Shaoming; Sherry, Nicole; Shoback, Dolores M.

Afiliação

Watts NB; Osteoporosis and Bone Health Services, Mercy Health, Cincinnati, OH 45236, USA.
Bilezikian JP; Division of Endocrinology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Bone HG; Michigan Bone and Mineral Clinic, PC, Detroit, MI 48236, USA.
Clarke BL; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN 55905, USA.
Denham D; Clinical Trials of Texas, Inc., San Antonio, TX 78229, USA.
Levine MA; Division of Endocrinology and Diabetes and Center for Bone Health, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Mannstadt M; Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Peacock M; Department of Medicine, Division of Endocrinology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Rothman JG; UPG-Endocrine (Research Division), Staten Island, NY 10301, USA.
Vokes TJ; Section of Endocrinology, University of Chicago Medicine, Chicago, IL 60637, USA.
Warren ML; Endocrinology and Metabolism, Physicians East, PA, Greenville, NC 27834, USA.
Yin S; Takeda Pharmaceuticals USA, Inc., Lexington, MA 02421, USA.
Sherry N; Takeda Pharmaceuticals USA, Inc., Lexington, MA 02421, USA.
Shoback DM; Endocrine Research Unit, San Francisco Veterans Affairs Medical Center, San Francisco, CA 94121, USA.